Standout Papers

Drotrecogin Alfa (Activated) in Adults with Septic Shock 2012 2026 2016 2021 859
  1. Drotrecogin Alfa (Activated) in Adults with Septic Shock (2012)
    V. Marco Ranieri, Bruce Thompson et al. New England Journal of Medicine
  2. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial (2018)
    Daniel J. Wallace, Richard Furie et al. The Lancet

Citation Impact

5 from Science/Nature 75 standout
Sub-graph 1 of 19

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
2023 Standout
1 intermediate paper

Works of Jonathan Janes being referenced

Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
2021
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
2018 Standout
and 1 more

Author Peers

Author Epidemiology Dermatology Surgery Immunology Last Decade Papers Cites
Jonathan Janes 1398 788 380 784 50 3.5k
M. J. Cherng 8 607
Sally J. Eder 71 1 126 11 25 413
Günfer Gürer 125 2 16 31 13 667
Kang Z. Liu 5 2 23 93 13 405
Nihal Kadıoğulları 4 1 268 18 387

All Works

Loading papers...

Rankless by CCL
2026